Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/ChiCTR2000035656
ChiCTR2000035656Not yet recruitingUnknown

一项微小残留病阳性急性早幼粒细胞白血病人的观察性研究

Not provided1 site in 1 country20 target enrollmentStarted: September 1, 2020Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Enrollment
20
Locations
1
Primary Endpoint
总生存期
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

评价微小残留病（MRD）阳性 APL 患者的预后。

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 70 (—)
Sex
All

Inclusion Criteria

  • •1）MRD 阳性（定量 PCR 检测 PML-RARA 阳性）的 APL。
  • •2）年龄 18-70 岁。
  • •3）东部肿瘤协作组(ECOG)体能状况评分为 0~2。
  • •5）可以提供知情同意书,可以理解并遵守研究各项要求。

Exclusion Criteria

  • Not provided

Arms & Interventions

case series

Outcomes

Primary Outcomes

总生存期

Secondary Outcomes

  • 微小残留病灶
  • 血常规
  • 热疗反应

Investigators

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Not Applicable
Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical CancerCervical Cancer
NCT07382505Asan Medical Center600
Unknown
Not Applicable
请在 ResMan IPD 平台上传原始数据以完成补注册。 MRD 转阳预测 MM 患者疾病进展
ChiCTR2100044792中山大学医学临床试验“5010 计划”31
Unknown
Not Applicable
盐酸米托蒽醌脂质体联合维甲酸及三氧化二砷降低高危急性早幼粒细胞白血病早期死亡率的临床研究
ChiCTR2500102949国家自然科学基金
Unknown
Not Applicable
基于危险度分层治疗的幼年型粒单核细胞白血病的多中心前瞻性临床研究
ChiCTR2000035471上海交通大学医学院150
Unknown
Not Applicable
基于急性髓系白血病 MRD 调整治疗方案的临床观察
ChiCTR2000033235国家自然科学基金青年项目（基金号 81800137）100